Name: Bilal Muhsin
New role: President of connected care, BD
Previous role: Chief operating officer, Masimo
BD said Monday that it has named Bilal Muhsin as president of its new connected care segment. The hire is effective as of July 2.
The company is creating the segment as part of the restructuring it announced in February. Connected care will house BD’s medication management and advanced patient monitoring devices, giving it control of products including the Pyxis line of automated dispensing systems and Alaris infusion pumps.
Muhsin has joined BD to help set up the new segment. Reporting to BD CEO Tom Polen, the executive will lead strategy development to support the transition to the revised structure over the next several months.
Polen said in a statement that Muhsin’s “extensive and deep knowledge of connected care technologies, software and informatics strategies” will help BD as it advances its connected care strategy. Muhsin developed the knowledge during his 25 years at Masimo, a medtech company that built a portfolio of patient monitoring devices around pulse oximeter technology.
Masimo told investors last month that Muhsin was resigning as chief operating officer to pursue other opportunities. The company, which did not replace Muhsin when he left on July 1, disclosed the change alongside an overhaul of its commercial leadership.
At BD, Muhsin will take over a connected care business that the company has grown through deals such as the $1.53 billion buyout of Parata Systems and $93 million acquisition of Medkeeper. The pharmacy robotics business that BD has built through the recent acquisitions sits alongside the Pyxis franchise that the company added to its portfolio through the $12.2 billion takeover of Carefusion in 2015.
The Pyxis business received a warning letter from the Food and Drug Administration last year and is now entering an important period. BD recently began shipping a new Pyxis device, Polen said at a Goldman Sachs event last month. The CEO said the launch could cause market share to “shift incrementally” and presents an opportunity to charge a price premium.
